Clear the name trap first: DocOn is not DocOnline. DocOn (docon.co.in) is the digital-prescription and EMR app for doctors, now in the PharmEasy family. DocOnline is a separate teleconsultation and corporate-health network, covered in our DocOnline comparison. If you’re a DocOn user weighing alternatives, the short version: DocOn digitises the prescription in seconds, and that’s genuinely useful, but a prescription is not a clinical note. An ambient AI scribe writes the whole note, from ₹1,599 per clinician a month on annual billing, plus 18% GST. Book a demo if you’d rather see that than read about it.
Key takeaways
- DocOn and DocOnline are different companies. This page covers DocOn, the Rx-and-EMR app; a separate post covers DocOnline.
- DocOn’s site claims 4,000+ verified doctors, 25M+ digital prescriptions, and prescriptions generated “within a few seconds”, with a 15-day trial and no published pricing.
- Its LinkedIn page describes it as acquired by PharmEasy; the product ties into e-pharmacy and e-diagnostics partners for home delivery.
- A fast Rx still leaves the note unwritten, and NMC’s 2023 regulations expect outpatient records kept 3 years.
- Patient Square drafts the full SOAP note, ICD-10 suggestions, and an Rx draft; entry is ₹1,599/month annual, ex-GST.
Which DocOn did you mean?
Two Indian health-tech brands sit one syllable apart, and they do completely different jobs. DocOn is software a doctor uses inside their own practice: an EMR built around producing a digital prescription fast, with a companion patient app. DocOnline is a service patients and employers buy: teleconsultations delivered by DocOnline’s own panel of doctors, sold as family plans and workplace-wellness programmes.
Search engines blur them. Your shortlist shouldn’t. If your question is “what replaces the network my employer buys consults from,” read the DocOnline alternatives post instead. Everything below is about DocOn, the Rx app in your pocket.
What DocOn does well
Credit where due, from their own published pages. DocOn pitches itself as a one-stop way to digitise a clinic, and the core promise is speed: “generate the prescription within a few seconds.” The site claims 4,000+ verified doctors across 20+ specialties and 100+ cities, more than 25 million digital prescriptions, and about a million prescriptions generated monthly. The app listing adds patient history on one screen, investigation storage, vaccination reminders, and growth charts, which explains its following among paediatricians. There’s a 15-day free trial; published pricing, as of this writing, there is none.
Then there’s the ownership, which matters more than most feature rows. DocOn’s LinkedIn page describes it as acquired by PharmEasy, and the product connects to e-pharmacy and e-diagnostics partners so patients can get medicines and lab tests delivered home. For patients, convenient. For the clinic, worth thinking through: the software sits upstream of a delivery business, and that’s part of why it can be priced the way it is. Not a red flag, just the model. Know whose funnel your prescription pad feeds.
A prescription is not a note
Here’s the wedge, stated plainly. An Rx that prints in seconds solves the last 30 seconds of the consult. It does nothing for the record of the other 90.
An Indore paediatrician clearing 90 patients a day on a fast Rx app ends the day with 90 tidy prescriptions and, very often, 90 near-empty records: drug names without the reasoning. Indian consultations average about two minutes, per a 67-country BMJ Open review. In that window, structured history, findings, assessment, and plan don’t get typed, whatever the software. The prescription is the one artefact that must exist for the patient to leave, so it’s the one artefact that does.
The gap has teeth. The National Medical Commission’s 2023 conduct regulations expect outpatient records kept for three years and produced on request, and when a treatment decision is questioned later, the prescription alone doesn’t explain why you chose that drug. The reasoning does, and the reasoning lives in the note nobody had time to write. Our medico-legal documentation post goes deeper on what a defensible record looks like.
Rx pad vs ambient documentation
| DocOn (published claims) | Patient Square (Practice Copilot) | |
|---|---|---|
| Core promise | Prescription “within a few seconds” | Full SOAP note drafted from the conversation |
| What you enter | Diagnosis, drugs; templates speed the pad | Nothing during the consult; you review after |
| Output | Digital Rx + EMR fields you fill | Structured note, ICD-10 suggestions, Rx draft |
| Patient-facing | Companion app, reminders, med delivery via partners | No patient marketplace; clinical tool only |
| Business model | PharmEasy family; e-pharmacy/diagnostics tie-ins | Per-clinician software subscription |
| Pricing | Not published; 15-day trial | Published: ₹1,599/mo entry, annual, ex-GST; 7-day trial |
If the second column is what your evenings are missing, book a demo and test it against a live OPD block.
When DocOn is the better choice
If your documentation need genuinely starts and ends at a fast, legible digital prescription with a patient app behind it, DocOn is the purpose-built tool, and switching would buy you nothing. High-volume OPDs that run on standard drug regimens, clinics that lean on the medicine-delivery tie-ins as a patient convenience, and paediatric practices using the growth-chart and vaccination features are all square in its lane. The 15-day trial costs nothing but time, and the app’s speed claims are the kind you can verify in an afternoon.
Be honest about one more case: if your notes are thin because you choose speed over narrative, and you’re comfortable with that trade, an ambient scribe solves a problem you’ve decided not to have.
The full-note alternative
The AI Medical Scribe by Patient Square is the ambient scribe module inside Practice Copilot. It listens during the visit and hands back a structured SOAP note, ICD-10 suggestions, and a prescription draft, ready to review and sign about two minutes after the visit. The prescription part of your workflow doesn’t get slower; it gets absorbed. You still review and sign every draft, eRx included, and the drafts arrive with the clinical reasoning already written around them.
It’s built for the consult as it actually sounds: English, Hindi, and 20+ Indian languages, code-mixing included, with the note always returned in clean clinical English. Audio is processed in memory and discarded once the note drafts. Records are handled to DPDP Act 2023 standards, a SOC 2 Type II audit is in progress, and every plan carries EHR-ready export (PDF · HL7 · FHIR), so notes move with you rather than locking you in. ABDM integration is on the roadmap, not live today, and we’d rather tell you that than badge it.
Pricing is published, which we think should be table stakes in this market. Assist is ₹1,599 per clinician per month on annual billing (₹1,999 monthly), ex-GST; with 18% GST that’s about ₹1,887. Copilot at ₹2,399 adds the bundled AI Copilot EHR and WhatsApp messaging. Unlimited visits and notes on every plan, no per-note metering, no setup fee. The ladder is on the India pricing page, and the wider e-prescription legal picture, what makes a digital Rx valid in India in the first place, is covered in our e-prescription validity checklist.
Run the honest test: same patients, one week, both tools. Count what’s in the record at 6pm. If the prescription pad is all you ever needed, DocOn earned its place. If the record should hold the reasoning too, book a demo and let the scribe write Tuesday’s notes.